Health, Novavax Covid-19 Vaccine: Trial Results From Us And Mexico Show 90.4% Efficacy - Cnn

Health, Novavax Covid-19 Vaccine: Trial Results From Us And Mexico Show 90.4% Efficacy - Cnn

Novavax says Covid-19 vaccine shows 90.4% overall efficacy in US/Mexico Phase 3 trial

CNN News, delivered. Select from our newsletters below and enter your email to subscribe.

6/14/2021 1:23:00 PM

JUST IN: Novavax says its coronavirus vaccine has an overall efficacy of 90.4% and was 'generally well-tolerated' in a Phase 3 trial in the US and Mexico

CNN News, delivered. Select from our newsletters below and enter your email to subscribe.

Additional analyses of the trial are ongoing, according to the company, and will be submitted to peer-reviewed journals for publication. Novavax to seek US authorization of its Covid-19 vaccine in third quarter, CEO saysThe trial results appear consistent with the efficacy and safety profile the vaccine previously showed in a Phase 3 trial conducted in the United Kingdom, Dr. Gregory Glenn, president of research and development for Novavax, told CNN."Different continent, different population, different viruses floating around, and yet, we still see really good efficacy," Glenn said."This is what you want to have."The study launched in December and enrolled 29,960 adults across 113 sites in the United States and six sites in Mexico. Some of the participants were given a placebo and some were administered two doses of the Novavax vaccine 21 days apart.Read MoreThe company said the vaccine was"generally well-tolerated" and common side effects included pain at the injection site, lasting less than three days, and fatigue, headache and muscle pain, lasting less than two days.How the Novavax Covid-19 vaccine worksThere were 77 Covid-19 cases that emerged among participants during the study, according to Novavax. Sixty-three of the cases were in people in the placebo group and 14 in the vaccine group. The company noted that all cases in the vaccine group were mild. There were 10 moderate and four severe cases in the placebo group, demonstrating a vaccine efficacy of 100% against moderate or severe disease, according to Novavax.Most cases were in"high-risk" people, such as those older than 65, with certain comorbidities or having frequent exposure to Covid-19. The company announced the vaccine's efficacy was 91% in"high-risk" populations.Novavax researchers also took a close look at sequencing data for 54 of the 77 Covid-19 cases in the study. Based on their sequencing of those cases, the company announced that the"vaccine efficacy was 93.2%" against variants of concern or of interest.A final analysis of Novavax's UK Phase 3 trial results, announced in March, showed that the vaccine had an overall efficacy of 89.7% -- and its efficacy was 96.4% against the original coronavirus strain and 86.3% against the B.1.1.7 variant first identified in the UK.Get CNN Health's weekly newsletter Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.

'Arthur' to end at PBS Kids with Season 25 in 2022 Opinion | Suni Lee and Simone Biles both represent the best of America Lorde Reveals the Musician She Wants to Collab With & Who Left Her Starstruck in '73 Questions': Watch Read more: CNN »

Biden town hall in Cincinnati: Live updates

President Biden will participate in a CNN town hall in Cincinnati, Ohio — a little more than six months after being sworn into office. Follow here for the latest news.

I invested $100 in bitcoin online trade with help from blincredits and made $1000 within a few hours duration trading from home. so excited and think it's nice sharing the news. Please help me! My name is Lin donglong, an employee of China telecom fuzhou branch. Company manager huang fei (communist party of China) organized the leadership of the gang of evil forces brutal persecution: surveillance location, insult,abuse, framed to take nude photos of me

Happy birthday Mr. President realDonaldTrump POTUS45 Best President ever! 2024 The real GOAT!! ❤️ Novavax researchers also took a close look at sequencing data for 54 of the 77 Covid - 19 cases in the study . There were 77 Covid -19 cases that emerged among participants during the study , according to Novavax .Sixty three cases were in the people in the placebo group and 14 in the vaccine group .

Good. Another vaccine to help get the world back to normal sooner The company said the vaccine was ' generally well- tolerated ' and common side effects included pain at the injection site , lasting less than three days , and fatigue ,, headache and muscle pain , lasting less than two days .

Novavax COVID-19 vaccine more than 90% effective in U.S. trialNovavax Inc (NVAX.O) on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.

good Some of the participants were given a placebo and some were administered two doses of the Novavax vaccine 21 days apart . The study launched in December and enrolled 29,960 adults across 113 sites in the United States and six sites in Mexico . I’ll wait for the peer review. Phase 3 phase 2 is still experimental,only this time we de people are the gunie pigs lab rats...yep!they invent the bio germ in a lab&tested it full scale on us unsuspecting ones,their objective cripple 🌎's economic system=CCP's XPING EMPOROR OF 🌎 China's way or de highway...

Great news Additional analysis of the trial are ongoing ,, according to the company ,and will be submitted to peer reviewed journals for publication. Generally well tolerated... Well that could have been worded better

Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic diseaseJUST IN: American biotechnology company Novavax announces that its experimental COVID-19 vaccine is more than 90% effective against symptomatic disease in late-stage clinical trials.

Novavax: Large study finds COVID-19 shot about 90% effectiveVaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico. The vaccine was about 90% effective overall and preliminary data showed it was safe, the company said. nauman_3 wait for this Lololol Is this a Novavax Jokavich? Get it?!

John Gabriel, Actor on ‘Ryan’s Hope,’ Dies at 90John Gabriel, the actor and singer who portrayed the controlling Dr. Seneca Beaulac for the first 10 years of the ABC soap opera Ryan’s Hope, has died. He was 90. Gabriel’s death was an… I TRULY LOVED him on Ryan’s Hope! May John Gabriel be Resting In Eternal Peace. 💔😭🙏🏼 And that God Blesses his Family and Friends. ❤️🙏🏼❤️ Awwww. I remember this.

John Gabriel Dies: ‘Ryan’s Hope’ Star, ‘Charles Grodin’ Talk Show Producer Was 90John Gabriel, the actor known for his turn in ABC soap opera Ryan’s Hope, has died. The Daytime Emmy nominee was 90 years old. While no details were immediately available regarding a cause of… Sad news to hear. Soap opera legend! May he rest in peace rip

Novavax COVID-19 vaccine more than 90% effective in U.S. trialNovavax Inc (NVAX.O) on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.